Robert P Ragusa
Director; Director, Chief Executive Officer · 5 filings · Latest: Sep 1, 2026
Alamar Biosciences, Inc.
GRAIL, Inc.
Twist Bioscience Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
GRAL | Robert P Ragusa | Director, Chief Executive Officer | Apr 8, 2026 | Sale | $49.92 | 123,502 | $6.2M | 518,582 | |
GRAL | Robert Ragusa | — | Apr 6, 2026 | Proposed Sale | $51.74 | 133,230 | $6.9M | — | |
GRAL | Robert P Ragusa | Director, Chief Executive Officer | Mar 9, 2026 | Sale | $47.89 | 7,461 | $357.3K | 642,084 | |
GRAL | Robert P Ragusa | Director, Chief Executive Officer | Mar 5, 2026 | Sale | $53.01 | 980 | $51.9K | 649,545 | |
GRAL | Robert Ragusa | — | Mar 5, 2026 | Proposed Sale | $51.80 | 9,285 | $481.0K | — | |
GRAL | Robert P Ragusa | Director, Chief Executive Officer | Mar 2, 2026 | Sale | $50.17 | 37,504 | $1.9M | 650,525 | |
GRAL | Robert Ragusa | — | Mar 2, 2026 | Proposed Sale | $53.23 | 40,641 | $2.2M | — | |
GRAL | ROBERT P RAGUSA | — | Dec 3, 2025 | Proposed Sale | $95.24 | 40,000 | $3.8M | — | |
GRAL | Robert Ragusa | — | Oct 15, 2025 | Proposed Sale | $69.29 | 8,275 | $573.4K | — | |
GRAL | Robert Ragusa | — | May 1, 2025 | Proposed Sale | $36.81 | 96,207 | $3.5M | — | |
GRAL | Robert Ragusa | — | Mar 5, 2025 | Proposed Sale | $36.33 | 9,102 | $330.7K | — | |
GRAL | Robert Ragusa | — | Oct 14, 2024 | Proposed Sale | $14.49 | 135,454 | $2.0M | — |